News

AffiPro is launching new RNase
T1 Column
for
online
RNA
Digestion

• Imobilized RNAase T1 for online digestion compatible with LCMS in a single workflow
• Proven RNAase T1 specificity with good reproducibility in subsequent LCMS runs
• Rapid analysis and increased throughput with minimal sample consumption

The Institute of Microbiology of the Czech Academy of Sciences is entering AffiPro s.r.o as a minority shareholder and strategic partner. By forming the joint venture with one of the largest institutes of the Czech Academy of Sciences, AffiPro is becoming its official spin-off company, and gains access to shared resources and priority licensing of technologies. Institute of Microbiology now owns 13.75% of the new entity, while 86.25% remains in the possession of the current owners of AffiPro. This join effort aims at Institute of Microbiology plans to commercialize some of its unique technologies while also helps AffiPro to intensify its activities in development of new tools for biotech industry and structural mass spectrometry.
https://lnkd.in/eAq6gMJE

Join Us at ASMS 2025 in Baltimore
📍 Booth #311 | 📅 June 1–5, 2025 | 🏙 Baltimore Convention Center

Visit us at Booth 311 to discover the latest in structural mass spectrometry and innovative solutions from our team.

Whether you want to learn about our newest developments, explore potential collaborations, or just catch up, we’d love to connect.

AffiPro is proud to partner with the Multiomics project under the Ministry of Education, Youth and Sports‘ Jan Amos Komenský Operational Programme (OP JAK). The Multiomics Project serves as a platform for identifying biological correlates of diseases and developing new diagnostic, preventive, and therapeutic approaches. The project builds on the longstanding collaboration between the First Faculty of Medicine at Charles University, the Institute of Biotechnology of the Czech Academy of Sciences, and the Institute of Microbiology of the Czech Academy of Sciences, all operating at the BIOCEV research center and two innovative application partners: GeneSpector, s.r.o., and Affipro, s.r.o.

Interested in the AffiPro MALDI chip technology? There will be two lectures at the ASMS 2024 in the Clinical Analysis: Innovations section covering this topic: TOE am 8:50 (Dvorak et al.) and TOE 9:10 (Volny et al.)

Stop by at the AffiPro booth 326 during the upcoming ASMS 2024 conference to see what is new! We are looking forward to meeting you in Anaheim!

The highly anticipated HDX meeting in Monterey is quickly approaching! We can’t wait to see you there in April

AffiPro will be participating as a sponsor at the Clinical & Translational Omics Symposium  on November 4th and 5th, 2023, in Protaras, Cyprus.

AffiPro is launching a new column hardware for Waters systems. As a benefit of co-marketing agreement with Waters, we are launching new series of our columns that have compatible fittings with Waters threads and 2.1x20mm dimensions. This new product line will be available in combination with all AffiPro enzymatic stationary phases. It is a useful addition to our currently available generic 2.1x20mm and 1.0x20mm hardware for customers who use chiefly Waters systems.

AffiPro is to attend the next HDX meeting in Monterey in 2024 as a sponsor. More about the meeting